Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy

Patient-derived organoid models help define personalized management of gastrointestinal cancer

(2018) M. R. Aberle et al.   BRITISH JOURNAL OF SURGERY

Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy

(2018) Albert Grinshpun et al.   CANCER BIOLOGY & THERAPY

Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics

(2018) Carmela Ricciardelli et al.   CANCER LETTERS

Establishment of patient-derived tumor spheroids for non-small cell lung cancer

(2018) Zengli Zhang et al.   PLoS One

The Generation and Application of Patient-Derived Xenograft Model for Cancer Research

(2018) Jaeyun Jung et al.   Cancer Research and Treatment

Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity

(2018) Gianpiero Lazzari et al.   Acta Biomaterialia

Affinity of human IgG subclasses to mouse Fc gamma receptors

(2017) Gillian Dekkers et al.   mAbs

Patient-derived xenografts as in vivo models for research in urological malignancies

(2017) Takahiro Inoue et al.   Nature Reviews Urology

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

(2017) Chantal Pauli et al.   Cancer Discovery

Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

(2017) David P. Kodack et al.   Cell Reports

Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma

(2016) D. Roife et al.   CLINICAL CANCER RESEARCH

Omics for personalized medicine: defining the current we swim in

(2016) Rania Ibrahim et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

The possibility of clinical sequencing in the management of cancer

(2016) Tadayuki Kou et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Patient-derived xenografts: a relevant preclinical model for drug development

(2016) Luca Pompili et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

(2016) Taofeek K. Owonikoko et al.   Journal of Translational Medicine

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

(2016) Shanthi Marur et al.   MAYO CLINIC PROCEEDINGS

Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation

(2016) Shirin Elhaik Goldman et al.   PLoS One

Changing paradigm of cancer therapy: precision medicine by next-generation sequencing

(2016) Yuan Xue et al.   Cancer Biology & Medicine

Organoid Models of Human and Mouse Ductal Pancreatic Cancer

(2015) Sylvia F. Boj et al.   CELL

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

(2015) Hui Gao et al.   NATURE MEDICINE

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

(2015) Biswanath Majumder et al.   Nature Communications

Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efficacy of Cetuximab

(2015) Rodney J. Taylor et al.   Cancer Immunology Research

Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes

(2015) Rami Yossef et al.   PLoS One

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance

(2013) M M Gerlach et al.   BRITISH JOURNAL OF CANCER

Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: Implications for the hosts’ innate immune response

(2013) Kiran Kundu et al.   CELLULAR IMMUNOLOGY

Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice

(2013) Marina Bersudsky et al.   GUT

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses

(2013) Darren R Tyson et al.   Personalized Medicine

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies

(2012) Lisa Licitra et al.   EUROPEAN JOURNAL OF CANCER

Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus

(2012) Kui Chen et al.   PLoS One

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

(2010) L. Licitra et al.   ANNALS OF ONCOLOGY

Head and neck cancer

(2010) David M. Cognetti et al.   CANCER

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE